SGNT
Sagent Pharmaceuticals, Inc.
NasdaqGS
People also watch:PCRXSUPNSCMPAKRXIRWD
21.670.00 (0.02%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close21.67
Open21.68
Bid21.67 x 16200
Ask21.68 x 2900
52wk Range10.55 - 25.17
Day's Range21.67 - 21.71
Volume207,747
Avg Vol (3m)858,811
As of 2:22 PM EDT. NasdaqGS Real Time Price. Market open.
  • Reuters2 days ago

    Teva, Allergan win U.S. antitrust approval for generics deal

    Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest 79 generic drugs to rival firms, the Federal Trade Commission said on Wednesday. The $40.5 billion deal, which was announced in July 2015, solidifies Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs. Teva will sell rights and assets related to the 79 pharmaceutical products to 11 rival firms, marking the largest ever drug divestiture order in an FTC pharmaceutical merger case, the commission said in a statement.

  • Zacks17 days ago

    Company News for July 12, 2016

    Companies In The News are: KMI,SO,SGNT,BA,OZRK